中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
  • 上海药物研究所 [14]
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共14条，第1-10条 帮助

限定条件                
条数/页： 排序方式：
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells 期刊论文  OAI收割
Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 6, 页码: 3013-3028
作者:  Wang, Ziruoyu;  Li, Yanan;  Zhao, Wensi;  Jiang, Shuai;  Huang, Yuqi
  |  收藏  |  浏览/下载：10/0  |  提交时间：2024/03/27
Rutaecarpine Promotes Adipose Thermogenesis and Protects against HFD-Induced Obesity via AMPK/PGC-1 alpha Pathway 期刊论文  OAI收割
PHARMACEUTICALS, 2022, 卷号: 15, 期号: 4, 页码: 18
作者:  Chen, Dandan;  Duan, Yanan;  Yu, Shuxiang;  Zhang, Xinwen;  Li, Ni
  |  收藏  |  浏览/下载：17/0  |  提交时间：2022/06/15
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文  OAI收割
CANCER SCIENCE, 2021, 页码: 12
作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang
  |  收藏  |  浏览/下载：87/0  |  提交时间：2022/01/18
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文  OAI收割
MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
  |  收藏  |  浏览/下载：87/0  |  提交时间：2021/11/04
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割
Molecular Cancer, 2021, 卷号: 20, 期号: 1
作者:  Zhang,Tao;  Qu,Rong;  Chan,Shingpan;  Lai,Mengzhen;  Tong,Linjiang
  |  收藏  |  浏览/下载：61/0  |  提交时间：2021/11/04
Simultaneous determination of sutetinib and its active metabolite sutetinibN-oxide in human plasma by liquid chromatography-tandem mass spectrometry: Evaluation of plasma stability 期刊论文  OAI收割
BIOMEDICAL CHROMATOGRAPHY, 2020, 页码: 9
作者:  Qiu, Yanan;  Tang, Chongzhuang;  Li, Ranran;  Cao, Sumin;  Zhang, Yuqiang
  |  收藏  |  浏览/下载：39/0  |  提交时间：2020/12/24
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
  |  收藏  |  浏览/下载：79/0  |  提交时间：2020/07/01
Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3 ',2 ':3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2 ',3 ': 4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5 '-monophosphate-activated protein kinase (AMPK) 期刊论文  OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 卷号: 26, 期号: 8, 页码: 2017-2027
作者:  Gu, Zhanni;  Wu, Lingyan;  Duan, Yanan;  Wang, Jiang;  Zhou, Shengbin
  |  收藏  |  浏览/下载：38/0  |  提交时间：2019/01/08
identificationofcompoundd2923asanovelantitumoragenttargetingcsf1r 期刊论文  OAI收割
actapharmacologicasinica, 2018, 卷号: 039, 期号: 011, 页码: 1768
作者:  Liu Yingqiang;  Wang Yanan;  Lu Xiaoyun;  Tong Linjiang;  Li Yan
  |  收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01
Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective alpha(1A)-Adrenoceptor Antagonists 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 8, 页码: 3826-3839
作者:  Zhao, Fei;  Li, Jing;  Chen, Ying;  Tian, Yanxin;  Wu, Chenglin
  |  收藏  |  浏览/下载：39/0  |  提交时间：2019/01/08